piracetam has been researched along with Astrocytosis in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our previous study showed that treatment with levetiracetam (LEV) after status epilepticus (SE) termination by diazepam might prevent the development of spontaneous recurrent seizures via the inhibition of neurotoxicity induced by brain edema events." | 7.83 | Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. ( Chiba, Y; Dohgu, S; Ishihara, Y; Itoh, K; Kataoka, Y; Komori, R; Nochi, H; Takata-Tsuji, F; Taniguchi, R; Ueno, M, 2016) |
| "Our previous study showed that treatment with levetiracetam (LEV) after status epilepticus (SE) termination by diazepam might prevent the development of spontaneous recurrent seizures via the inhibition of neurotoxicity induced by brain edema events." | 3.83 | Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. ( Chiba, Y; Dohgu, S; Ishihara, Y; Itoh, K; Kataoka, Y; Komori, R; Nochi, H; Takata-Tsuji, F; Taniguchi, R; Ueno, M, 2016) |
| "Levetiracetam (LEV, 2S-(oxo-1-pyrrolidinyl)butanamide, Keppra, UCB Pharma) is a new anti-epileptic drug used to treat certain types of seizures in epilepsy patients." | 3.76 | Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. ( Choi, HC; Choi, SY; Jo, SM; Kang, TC; Kim, DS; Kim, JE; Kim, YI; Song, HK, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, K | 1 |
| Ishihara, Y | 1 |
| Komori, R | 1 |
| Nochi, H | 1 |
| Taniguchi, R | 1 |
| Chiba, Y | 1 |
| Ueno, M | 1 |
| Takata-Tsuji, F | 1 |
| Dohgu, S | 1 |
| Kataoka, Y | 1 |
| Kim, JE | 1 |
| Choi, HC | 1 |
| Song, HK | 1 |
| Jo, SM | 1 |
| Kim, DS | 1 |
| Choi, SY | 1 |
| Kim, YI | 1 |
| Kang, TC | 1 |
2 other studies available for piracetam and Astrocytosis
| Article | Year |
|---|---|
Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.
Topics: Acute Disease; Animals; Anticonvulsants; Astrocytes; Blood-Brain Barrier; Brain Edema; Capillary Per | 2016 |
Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats.
Topics: Animals; Anticonvulsants; Astrocytes; Chronic Disease; Epilepsy; Gliosis; Hippocampus; Interleukin-1 | 2010 |